| Israel | Turquia | Áustria | |
| Transplante de medula óssea | de $255,000 | de $27,500 | de $140,000 |
| Sistema Robótico Da Vinci | de $26,000 | de $9,500 | de $22,000 |
| Remoção de tumor cerebral | de $30,000 | de $25,850 | de $60,000 |
| Remoção de cancro do fígado | de $5,000 | de $10,800 | de $40,000 |
| Quimioterapia | de $620 | de $3,000 | de $2,500 |
A Bookimed não adiciona taxas extras aos preços de tratamento de Oncologia. As tarifas vêm das listas oficiais das clínicas. O pagamento é feito diretamente na clínica na chegada ao país.
A Bookimed está comprometida com sua segurança. Trabalha apenas com instituições que mantêm altos padrões internacionais no tratamento de Oncologia e têm as licenças necessárias para atender pacientes internacionais em todo o mundo.
A Bookimed oferece assistência gratuita de especialistas. Um coordenador médico pessoal apoia antes, durante e após o tratamento, solucionando problemas. Nunca está sozinho em sua jornada de tratamento de Oncologia.
Dr. Auala Hubert is a board-certified medical oncologist and radiotherapist with 33 years of clinical experience. She works at Hadassah Medical Center and speaks both English and Hebrew. Dr. Hubert leads the Gastrointestinal Cancer Center. She is also a senior physician in the Oncology Department.
She earned her M.D. from Hadassah University Hospital. She holds board certifications in oncology and radiotherapy. Dr. Hubert has passed USMLE Parts I and II. She is a member of the Israel Society of Clinical Oncology, Israel Medical Society, and Israel Cancer Association. Dr. Hubert also serves on several medical and social service committees, where she helps advance cancer care.
Dr. Michael Lotem leads the Melanoma and Cancer Immunotherapy Center at Hadassah Medical Center. He specializes in advanced immunotherapy for melanoma. He is known for his research on SLAM receptors and their role in anti-cancer immune responses. Dr. Lotem has published widely in leading medical journals.
He heads a multidisciplinary team that uses clinical data and patient samples to advance research. Under his leadership, the center has improved patient outcomes with new therapies. The center is now recognized as a leader in cancer immunotherapy.
Dr. Alon Pikarsky is a board-certified general and colorectal surgeon at Hadassah Medical Center. He received his Israel Board Certification in General Surgery in 1998. He has led the Medical Students Program in Surgery since 1997. Since 2000, he has also served as Residency Program Director.
Dr. Pikarsky is known for his academic leadership. He has worked as an instructor in surgery since 1995, a lecturer since 1999, and a senior lecturer since 2005. He is an active member of several surgical associations. Dr. Pikarsky speaks both English and Hebrew fluently.
Todo o conteúdo médico desta página é preparado por autores com formação médica especializada e revisto por médicos certificados na área relevante. Revisão médica por Yesim Yildirim, Clinical oncologist.
Última actualização: October 30, 2025.
Todos os dados são fornecidos para fins informativos gerais e podem não representar resultados ou experiências individuais.